Showing results (171-180 of 226) with videos related to

Sort By:
Pageof 23
Respiratory Medicine|June 30, 2018
Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumoniaForest W Arnold, Gustavo Lopardo, Timothy L Wiemken, et al.
Lung|November 11, 2015
Macrolide Use and Neutrophil Function/Cytokine Levels in Hospitalized Patients with Community-Acquired Pneumonia: A Pilot StudyForest W Arnold, Jose Bordon, Rafael Fernandez-Botran, et al.
American Journal of Infection Control|November 24, 2016
Process control charts in infection prevention: Make it simple to make it happenTimothy L Wiemken, Stephen P Furmanek, Ruth M Carrico, et al.
The Journal of the Kentucky Medical Association|October 19, 2007
Establishing a hospital program to improve antimicrobial use, control bacterial resistance and contain healthcare costs: the University of Louisville experienceForest W Arnold, Alpa Patel, Raul Nakamatsu, et al.
International Journal of Antimicrobial Agents|October 7, 2008
A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibioticThomas M File, Scott V Monte, Jerome J Schentag, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 17, 2012
Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumoniaJose Bordon, Stefano Aliberti, Rafael Fernandez-Botran, et al.
International Journal of Antimicrobial Agents|May 22, 2018
Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infectionsDavid B Huang, G Ralph Corey, Thomas L Holland, et al.
Postgraduate Medicine|November 27, 2009
Higher pneumococcal disease vaccination rates needed to protect more at-risk US adultsSusan J Rehm, Monica M Farley, Thomas M File, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2019
Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) TrialThomas M File, Lisa Goldberg, Anita Das, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 19, 2014
Impact of an antimicrobial stewardship program on patients with acute bacterial skin and skin structure infectionsTimothy R Pasquale, Tamara L Trienski, Deanna E Olexia, et al.
Pageof 23